Showing results (311-320 of 319) with videos related to
Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 319 results.
Cell Reports. Medicine|October 27, 2023
Prior antibiotic administration disrupts anti-PD-1 responses in advanced gastric cancer by altering the gut microbiome and systemic immune responseChang Gon Kim, June-Young Koh, Su-Jin Shin, et al.Cancer Research and Treatment|March 15, 2021
Guidelines for Cancer Care during the COVID-19 Pandemic in South KoreaJii Bum Lee, Minkyu Jung, June Hyuk Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2019
Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction AdenocarcinomaRonan J Kelly, Jeeyun Lee, Yung-Jue Bang, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 4, 2021
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 studyYoon-Koo Kang, Satoshi Morita, Taroh Satoh, et al.Breast Cancer Research and Treatment|September 23, 2021
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimensMing Shen Dai, Yin Hsun Feng, Shang Wen Chen, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 15, 2019
Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancerHyo Song Kim, Woong Sub Koom, Song-Ee Baek, et al.Neuro-Oncology|December 1, 2021
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumorsFrançois Doz, Cornelis M van Tilburg, Birgit Geoerger, et al.Gut|November 12, 2014
Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomasSuling J Lin, Johann A Gagnon-Bartsch, Iain Beehuat Tan, et al.Cancer Research and Treatment|April 26, 2018
Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer PatientsSe-Hoon Lee, Boram Lee, Joon Ho Shim, et al.Pageof 32